Evidence map›Paper›PMID 41726907›Full record

ArticlebioRxiv : the preprint server for biology2026

Elevated endocytic trafficking mediated by GPRASP2 maintains HSC fidelity.

Alanna V Van Huizen, Mattieu Zhai, Haruhito Totani, Dewmi Rathnayake, Emilia E Kooienga, Ishani Sharma, Zakiya R Kelley, Madeleine Rodgers, Federica Zanotti, Lance Palmer and 9 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Alanna V Van HuizenDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Mattieu ZhaiDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Haruhito TotaniRuth L. and David S. Gottesman Institute for Stem Cell, Regenerative Medicine Research, Department of Cell Biology and Stem Cell Institute, Albert Einstein College of Medicine, Bronx, NY, USA.
Dewmi RathnayakeDepartment of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Emilia E KooiengaDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ishani SharmaDepartment of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Zakiya R KelleyDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Madeleine RodgersDepartment of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Federica ZanottiRuth L. and David S. Gottesman Institute for Stem Cell, Regenerative Medicine Research, Department of Cell Biology and Stem Cell Institute, Albert Einstein College of Medicine, Bronx, NY, USA.
Lance PalmerDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Kate TisdaleDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Preeti DabasDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jessica NunesDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Dirk LoefflerDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID 0000-0001-9870-0088
Shondra Pruet-MillerDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jonathon KleinDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Keisuke ItoRuth L. and David S. Gottesman Institute for Stem Cell, Regenerative Medicine Research, Department of Cell Biology and Stem Cell Institute, Albert Einstein College of Medicine, Bronx, NY, USA.
Antonio Morales-HernándezDepartment of Pathology and Laboratory Medicine, St. Jude Children's Research Hospital, Memphis, TN, USA; Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, MI, USA.
Shannon McKinney-FreemanDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Shondra Michelle Miller · 1985 to 2026
$166.9M
PROFESSIONAL ONCOLOGY EDUCATION PROGRAMR25CA023944 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI SUZANNE A. GRONEMEYER · 1986 to 2026
$8.3M
Investigating the mechanisms of lysosome segregation and cell fate regulation in dividing hematopoietic stem cellsR01HL174644 · NHLBI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Dirk Loeffler · 2024 to 2026
$2.3M
Childhood Hematological Malignancies Training ProgramT32CA236748 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Charles G Mullighan · 2019 to 2026
$2.0M
Defining Nfix's role as a novel key regulator of hematopoietic stem cellsR01DK104028 · NIDDK · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MCKINNEY-FREEMAN, SHANNON L · 2016 to 2020
$2.0M
GPRASP family as novel regulators in hematopoietic stem cellsR00DK123395 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MORALES-HERNANDEZ, ANTONIO · 2023 to 2025
$737k
Gprasp2 expression identifies a deeply quiescent hematopoietic stem cells subset with superior stemness and self-renewalF32DK135334 · NIDDK · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI VAN HUIZEN, ALANNA V · 2023 to 2023
$70k
NCI NIH HHS P30 CA021765NCI NIH HHS P30 CA046592NCI NIH HHS R25 CA023944NCI NIH HHS T32 CA236748NHLBI NIH HHS R01 HL174644NIDDK NIH HHS F32 DK135334NIDDK NIH HHS R00 DK123395NIDDK NIH HHS R01 DK104028
6 · The paper itself

Abstract

Endolysosomal trafficking supports cellular homeostasis through coordinated regulation of extrinsic signaling inputs. Hematopoietic stem cell (HSC) function requires a tightly regulated balance between quiescence for long-term preservation and rapid activation for blood production. Although lysosomal regulation of metabolism and quiescence has been linked to stem cell maintenance, the contribution of endocytic routing to lysosomal function remains incompletely understood. Here, we show that quiescent HSCs rely on elevated endocytosis to maintain self-renewal. This activity is mediated in part by GPRASP2, a post-endosomal sorting protein. HSCs enriched in GPRASP2 are functionally dormant yet molecularly primed for activation however, in response to proliferative cues, dormant HSCs exhibit reduced signaling and proliferation. Disruption of GPRASP2-mediated endocytosis induces rapid proliferation and increased expression of signaling constituents, consistent with a model in which elevated endocytosis attenuates signaling through receptor internalization. Thus, we identify endocytosis as a mechanism by which HSCs limit functional exhaustion arising from chronic activation.

Identifiers

PMID41726907
PMCPMC12919065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.